Recently Released Market Study: Impax Laboratories, Inc. (Formerly Global Pharmaceutical Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

New Healthcare market report from MarketLine: "Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report"

Logo

Boston, MA -- (ReleaseWire) -- 01/31/2014 --MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Report Description:

MarketLines' Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation) since January 2007.

View Full Report Details and Table of Contents

Scope of this Report:

- Provides intelligence on Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation)'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation) and its subsidiaries since 2007.
- Information about key financial and legal advisors for Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation)'s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Report Highlights:

This report includes Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation)'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation). These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to Get this Report:

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation)'s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors' business structure and growth strategies.

Companies Mentioned in this Report: Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation)

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

- Medicis Pharmaceutical Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Mylan Laboratories Limited (formerly Matrix Laboratories Limited) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- North China Pharmaceutical Group Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Stratos Global Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Global Hyatt Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Caraco Pharmaceutical Laboratories, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- HST Global, Inc. (formerly NT Holding Corp.; ABSS Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- DGT Holdings Corp. (formerly Del Global Technologies Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Aureon Biosciences, Inc. (formerly Aureon Biosciences Corporation; Aureon Laboratories, Inc.; Aurigen Bioscience, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- China Power Investment Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Media Relations Contact

Bill Thompson
Director of Marketing
800-844-8156
http://www.fastmr.com

View this press release online at: http://rwire.com/452083